Surendra K Ajjarapu
CIK 1368298 · View on SEC EDGAR ↗
First SEC filing: Feb. 24, 2025 · Latest: Feb. 24, 2025
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Nov. 15, 2017 | SCNX | S | 250,000 | $112500.00 | $28,125,000,000 | 13,743,750 Direct | -1.79% | Disposed | -100.0% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 22, 2026 | MEDS | Warrant | Common Stock (100,000) | $0.00 | March 31, 2031 | 100,000 | Acquired |
| March 31, 2026 | MEDS | Warrant | Common Stock (5,000,000) | $0.00 | March 31, 2031 | 5,000,000 | Acquired |
| May 13, 2019 | SCNX | Stock Option | Common Stock (100,000) | $0.44 | May 13, 2019 | 100,000 | Acquired |
| June 17, 2008 | AMTX | Employee Stock Option (right to buy) | Common Stock (300,000) | $3.70 | June 16, 2013 | 300,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 7 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| July 24, 2026 | FLZH | Common Stock | 2,726,538 | Indirect |
| July 24, 2026 | FLZH | Common Stock | 2,759,074 | Indirect |
| Feb. 24, 2025 | MEDS | Common Stock, par value $0.0001 | 3,863,200 | Indirect |
| Feb. 24, 2025 | MEDS | Common Stock, par value $0.0001 | 2,500,000 | Indirect |
| Dec. 11, 2007 | AMTX | Common | 6,900,000 | Direct |
| Dec. 11, 2007 | AMTX | Stock Option→ Common Stock (300,000) | 300,000 | Direct |
| Dec. 11, 2007 | AMTX | Stock Option→ Common Stock (90,000) | 90,000 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $484,154 | — | $25,000 | — | — | — | $60,923 | $570,577 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.